FGFR1 and leukemia: The R661P substitution disrupts this inhibitory hydrogen bond interaction, potentially altering the regulation of FGFR1’s kinase activity [20].Cowell et al. observed the V561M mutation in FGFR1 in leukemia and lymphomas.